(Q48221828)

9 February 2018

title

Addition of IFN-alpha to treatment of malignant brain tumors (English)

1 reference

9 February 2018

author name string

Jereb B

1

1 reference

9 February 2018

Petric-Grabnar G

2

1 reference

9 February 2018

Klun B

3

1 reference

9 February 2018

Lamovec J

4

1 reference

9 February 2018

Skrbec M

5

1 reference

9 February 2018

Soos E

6

1 reference

9 February 2018

publication date

1 January 1994

1 reference

9 February 2018

published in

Acta Oncologica

1 reference

9 February 2018

volume

33

1 reference

9 February 2018

issue

6

1 reference

9 February 2018

page(s)

651-654

1 reference

9 February 2018

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery

cites work

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121777

Postoperative radical radiotherapy with concurrent weekly intra-arterial cis-platinum for treatment of malignant glioma: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121777

Adjuvant intraarterial chemotherapy with nimustine in the management of World Health Organization Grade IV gliomas of the brain. Experience at the Department of Neurosurgery of Düsseldorf University

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121777

Systemic gamma-interferon therapy for recurrent gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121777

Immunobiology of primary intracranial tumors. Part 10: Therapeutic efficacy of interferon in the treatment of recurrent gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121777

Intratumor administration of beta-interferon in recurrent malignant gliomas. A phase I clinical and laboratory study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121777

Effect of human leukocyte interferon on malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121777

Neurotoxicity of intraventricularly administered alpha-interferon for leptomeningeal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121777

Neuropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121777

Human leukocyte interferon (HuIFN-alpha): potent endorphin-like opioid activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121777

Subacute brain atrophy after radiation therapy for malignant brain tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121777

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869409121777

10.3109/02841869409121777

21 January 2018

Identifiers

DOI

1 reference

9 February 2018

1 reference

9 February 2018